Antiviral Drugs for Cirrhosis and Hepatitis

Viruses are the intracellular parasites that depend on synthetic processes of host cells. They cannot be grown on ordinary medium. Special microscopes are needed to visualize their structure, which consists of Genome (genetic material consisting of DNA or RNA component but never both), Surrounding capsid –proteinaceous in structure, Envelope –protein bilayer. Hepatitis B virus (HBV) is an important cause of end-stage liver disease and hepatocellular carcinoma (HCC). The decision to treat is based on the activity of liver disease and HBV replication status, and the likelihood of a long-term benefit. Approved therapies include standard and pegylated interferon-alfa and nucleoside analogues: lamivudine, adefovir and entecavir. Even with successful therapy, patients remain at risk for reactivation of viral replication and require lifelong monitoring.

HBV in HBsAg-positive patients treated with allogeneic hematopoietic cell transplantation. Highly active antiretroviral therapy is initiated for decreasing mortality relating to HIV. Influenza can be type A, B or C depending upon type. Influenza A and B are more common.

  • Anti-retroviral agents
  • Antiviral Regimens
  • Anti-herpes virus agents
  • Anti influenza agents

Related Conference of Antiviral Drugs for Cirrhosis and Hepatitis

December 17-18, 2018

3rd World Liver Congress

Abu Dhabi, UAE
January 30-31, 2019

16th World Congress on Gastroenterology & Therapeutics

Bangkok, Thailand
January 30-31, 2019 |

World Congress on Pancreatic Cancer and Liver Diseases

Radisson Hotel Narita | Tokyo, Japan
March 04-05, 2019

20th World Congress on Gastroenterology

Berlin, Germany
April 24-25, 2019

International conference on Liver and Hepatitis

Budapest, Hungary
May 15-16, 2019

21st World Congress on Advances in Gastroenterology and Hepatology

Mercure Melbourne Albert Park, Melbourne, Australia
July 08-09, 2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
September 23-24, 2019

World Summit on Liver Cirrhosis and Hepatitis

Tokyo, Japan
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia

Antiviral Drugs for Cirrhosis and Hepatitis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in